{
    "patientData": {
        "name": "Sarah Miller",
        "mrn": "MC-001001",
        "age_sex": "63-year-old Female",
        "date_of_summary": "2025-10-14",
        "one_sentence_impression": "Acute liver injury likely DILI and/or severe methotrexate toxicity in a patient with rheumatoid arthritis, hypertension, and CKD.",
        "clinical_context_baseline": {
            "comorbidities": [
                "Rheumatoid arthritis",
                "Essential hypertension",
                "Mild chronic kidney disease"
            ],
            "key_baseline_labs": "Baseline labs (2015-2021) show normal LFTs, Creatinine ~0.9-1.4 mg/dL, eGFR ~58-85 mL/min/1.73m2.",
            "social_history": "Drinks ~1–2 beers/day (7–14 units/week). Smoked ~1 pack/day (35 pack-year history), quit in 2017. Retired carpenter."
        },
        "suspect_drug_timeline": {
            "chief_complaint": "Severe fatigue, jaundice, epigastric pain, confusion.",
            "hopi_significant_points": "63-year-old female with RA, HTN, CKD presented with 24h severe fatigue, jaundice, epigastric pain, confusion. Started TMP-SMX 6 days prior for sinusitis. Noted mouth ulcers 4-6 days ago. Recent labs show markedly elevated LFTs and bilirubin.",
            "chronic_medications": [
                "Methotrexate 20 mg weekly",
                "Folic Acid 5 mg weekly",
                "Lisinopril 10 mg daily"
            ],
            "acute_medication_onset": "Trimethoprim-Sulfamethoxazole 800/160 mg BID started 2025-06-15.",
            "possibilities_for_dili": [
                "Trimethoprim-Sulfamethoxazole",
                "Methotrexate"
            ]
        },
        "rule_out_complete": {
            "viral_hepatitis": "Pending serology.",
            "autoimmune": "No specific workup mentioned beyond RUCAM. No prior history.",
            "other_competing_dx_ruled_out": "No fever or hemodynamic instability to suggest ischemic or septic hepatitis. No autoimmune or metabolic history."
        },
        "injury_pattern_trends": {
            "pattern": "Hepatocellular injury (ALT/AST >> Alk Phos).",
            "hys_law": "Meets Hy's Law criteria with ALT/AST >20x ULN and Total Bilirubin >3x ULN.",
            "meld_na": "Not calculable from provided data, but high bilirubin and INR suggest severe injury.",
            "lft_data_peak_onset": {
                "ALT": "1650 U/L",
                "AST": "2100 U/L",
                "Alk_Phos": "350 U/L",
                "T_Bili": "12.5 mg/dL",
                "INR": "1"
            },
            "lft_sparklines_trends": "Baseline LFTs were normal. Acute elevation noted on 2025-06-21.",
            "complications": [
                "Hepatic Encephalopathy (confusion, disorientation, asterixis, GCS 13)",
                "Acute Liver Failure"
            ],
            "noh_graz_law": "Not applicable (not paracetamol toxicity)."
        },
        "severity_prognosis": {
            "severity_features": [
                "Jaundice",
                "Hepatic Encephalopathy",
                "Marked Transaminitis",
                "INR 1 (but low WBC and platelets noted in ED)"
            ],
            "prognosis_statement": "Patient meets criteria for acute liver failure, a life-threatening condition requiring intensive management and monitoring for potential liver transplantation."
        },
        "key_diagnostics": {
            "imaging_performed": "Point-of-care ultrasound of IVC performed, showing minimally collapsible IVC.",
            "biopsy": "Not mentioned.",
            "methotrexate_level": "Ordered urgently on 2025-06-21."
        },
        "management_monitoring": {
            "stopped_culprit_drugs": [
                "Methotrexate",
                "Trimethoprim-Sulfamethoxazole"
            ],
            "active_treatments": [
                "N-acetylcysteine",
                "IV fluids"
            ],
            "consults_initiated": [
                "Hepatology",
                "Gastroenterology",
                "Hematology",
                "Intensive Care Unit (ICU) admission"
            ],
            "nutrition": "NPO initially.",
            "vte_ppx": "Not mentioned.",
            "causality_rucam": "RUCAM score is 7, categorized as 'Probable' for TMP-SMX as the primary culprit and Methotrexate as a significant co-factor.",
            "monitoring_plan": [
                "Frequent neuro checks",
                "Liver function tests",
                "CBC",
                "Coagulation panel",
                "Renal function tests",
                "Methotrexate levels"
            ]
        },
        "current_status_last_48h": "Patient presented with acute liver failure and encephalopathy on 2025-06-21. Management initiated with discontinuation of offending agents, NAC, and ICU admission. Current status and trends are not detailed beyond initial presentation."
    }
}